Paolo A. Ascierto
ScholarGPS® ID: 34703929405659
Affiliation History
Field
Medicine
Discipline
Oncology
Top Specialties
Melanoma | Cancer | Immunotherapy | Translational Medicine | Nivolumab | Cancer Immunotherapy | Neoplasm | Mutation | Biomarker | Checkpoint Inhibitor | Interferon | Antibody | Cancer Immunology | Combination Therapy | Immune Checkpoint
Metrics Summary
Publication Count
902
Predicted Citations
74,307
Predicted h-index
110
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Journal of Clinical Oncology, volume 42, issue 17_suppl, pages LBA9516-LBA9516 (2024). |
Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma (journal article) Cancer Immunology, Immunotherapy, volume 73, issue 8 (2024). |
Effect of anti CTLA-4 and PD-1 monoclonal antibodies on systemic SDF-1 and galectin-3 levels through NLRP3 and MyD-88 pathways in preclinical models. (journal article) Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 12032-12032 (2024). |
Fasting mimicking diet reduces anti-OX40/anti PD-L1 and anti-PD-1/anti-CTLA-4 cardiovascular side effects in preclinical melanoma models. (journal article) Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 12029-12029 (2024). |
Journal of Clinical Oncology, volume 42, issue 16_suppl, pages e24016-e24016 (2024). |
Italian Journal of Dermatology and Venereology, volume 159, issue 3 (2024). |
Use of artificial intelligence chatbots in clinical management of immune-related adverse events (journal article) Journal for ImmunoTherapy of Cancer, volume 12, issue 5, pages e008599- (2024). |
Merkel-cell carcinoma: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up (journal article) ESMO Open, volume 9, issue 5, pages 102977- (2024). |
The Dysregulation of the Monocyte–Dendritic Cell Interplay Is Associated with In-Hospital Mortality in COVID-19 Pneumonia (journal article) Journal of Clinical Medicine, volume 13, issue 9, pages 2481- (2024). |
Frontiers in Oncology, volume 14 (2024). |
Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological Characteristics (journal article) The Oncologist, volume 29, issue 4, pages e447-e454 (2024). |
Methylation-sensitive restriction enzyme-droplet digital PCR assay for the one-step highly sensitive analysis of DNA methylation hotspots (journal article) International Journal of Molecular Medicine, volume 53, issue 5 (2024). |
Journal of Translational Medicine, volume 22, issue 1 (2024). |
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors (journal article) Cell Death & Disease, volume 15, issue 3 (2024). |
Tirbanibulin ointment to manage recurrence of superficial basal cell carcinoma of the face: case report (journal article) Clinical and Experimental Dermatology, volume 49, issue 2, pages 183-185 (2024). |
Frontiers in Cardiovascular Medicine, volume 11 (2024). |
EJC Skin Cancer, volume 2 (2024). |
EJC Skin Cancer, volume 2 (2024). |
EJC Skin Cancer, volume 2 (2024). |
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study (journal article) The Lancet Oncology, volume 24, issue 12, pages e461-e471 (2023). |